- December 6, 2022
- 10:00 AM - 3:30 PM ET
- Organized By:
Recording and presentations
Responses to questions asked at the FDA BAA Day event are now available.
2022 FDA Broad Agency Announcement Day
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. Join us to learn more about the FY 2023 BAA, and how to apply.
Please register in advance to attend this event. Upon registering, you will receive an email including log-in information, and downloadable calendar reminder. There is no cost to attend, and you may cancel your registration at any time.
Agenda and speaker information
The FDA BAA is open to all responsible sources, and small businesses are strongly encouraged to respond. Offerors may include single entities or teams from private sector organizations, Federally Funded Research and Development Centers (FFRDCs), and academic institutions.
FY 2023 BAA solicitation
FDA solicits for advanced research and development proposals to support regulatory science and innovation. FDA anticipates that research and development activities awarded under this BAA will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation.
View the FY23 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science on SAM.gov. For details, including research areas of interest, please see the full BAA PDF (788 KB - link updated).
For consideration in FY 2023, white papers are due by 5:00 p.m. EST, January 23, 2023. Join us at FDA BAA Day to learn more about the application process.
Contact us / submit a question
Please contact FDABAA@fda.hhs.gov with questions, including any questions you'd like us to answer at this event.